| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endosonography | 25 | 2024 | 99 | 4.760 |
Why?
|
| Endoscopic Mucosal Resection | 8 | 2024 | 28 | 3.180 |
Why?
|
| Endoscopy, Gastrointestinal | 15 | 2024 | 160 | 2.840 |
Why?
|
| Colonic Polyps | 8 | 2024 | 132 | 2.250 |
Why?
|
| Endoscopy | 11 | 2023 | 351 | 2.100 |
Why?
|
| Colonoscopy | 13 | 2024 | 280 | 1.740 |
Why?
|
| Esophageal Neoplasms | 11 | 2023 | 332 | 1.710 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 12 | 2024 | 67 | 1.710 |
Why?
|
| Bacteria | 13 | 2021 | 479 | 1.510 |
Why?
|
| Barrett Esophagus | 7 | 2023 | 93 | 1.450 |
Why?
|
| Gastric Outlet Obstruction | 2 | 2021 | 10 | 1.400 |
Why?
|
| Pancreatic Diseases | 6 | 2018 | 53 | 1.330 |
Why?
|
| Stomach Neoplasms | 7 | 2024 | 287 | 1.310 |
Why?
|
| Pancreatic Neoplasms | 13 | 2021 | 677 | 1.310 |
Why?
|
| Gastrointestinal Neoplasms | 4 | 2024 | 112 | 1.290 |
Why?
|
| Deglutition Disorders | 3 | 2021 | 119 | 1.280 |
Why?
|
| Gastroenterology | 6 | 2024 | 146 | 1.270 |
Why?
|
| Pancreatitis, Chronic | 3 | 2017 | 54 | 1.180 |
Why?
|
| Esophageal Stenosis | 4 | 2023 | 26 | 1.170 |
Why?
|
| Microbial Consortia | 4 | 2015 | 13 | 1.170 |
Why?
|
| Adenoma | 6 | 2016 | 247 | 1.140 |
Why?
|
| Endoscopy, Digestive System | 5 | 2020 | 68 | 1.130 |
Why?
|
| Equipment Contamination | 3 | 2021 | 23 | 1.080 |
Why?
|
| Stents | 12 | 2024 | 406 | 1.080 |
Why?
|
| Duodenoscopes | 4 | 2023 | 7 | 1.070 |
Why?
|
| Fellowships and Scholarships | 4 | 2024 | 124 | 1.050 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2018 | 98 | 1.040 |
Why?
|
| Disinfection | 3 | 2021 | 15 | 1.010 |
Why?
|
| Humans | 116 | 2024 | 89477 | 1.000 |
Why?
|
| Gastroenterostomy | 3 | 2021 | 7 | 0.990 |
Why?
|
| Adenocarcinoma | 11 | 2021 | 1200 | 0.980 |
Why?
|
| Drainage | 6 | 2023 | 164 | 0.960 |
Why?
|
| Microbiota | 11 | 2015 | 403 | 0.960 |
Why?
|
| Biopsy, Fine-Needle | 7 | 2011 | 107 | 0.940 |
Why?
|
| Cholestasis | 4 | 2019 | 45 | 0.880 |
Why?
|
| Gallbladder | 1 | 2023 | 31 | 0.870 |
Why?
|
| Cholecystitis, Acute | 1 | 2023 | 8 | 0.870 |
Why?
|
| Fibrosis | 1 | 2024 | 234 | 0.830 |
Why?
|
| Cross Infection | 2 | 2021 | 148 | 0.830 |
Why?
|
| Soil Microbiology | 5 | 2015 | 25 | 0.820 |
Why?
|
| Gastrointestinal Tract | 5 | 2015 | 191 | 0.820 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2021 | 7 | 0.790 |
Why?
|
| Intestinal Perforation | 1 | 2021 | 36 | 0.780 |
Why?
|
| Endoscopes | 2 | 2021 | 9 | 0.780 |
Why?
|
| Narrow Band Imaging | 4 | 2017 | 6 | 0.780 |
Why?
|
| Metagenomics | 4 | 2014 | 91 | 0.760 |
Why?
|
| Diarrhea | 2 | 2016 | 182 | 0.760 |
Why?
|
| Colorectal Neoplasms | 7 | 2024 | 983 | 0.750 |
Why?
|
| Anastomotic Leak | 4 | 2019 | 103 | 0.700 |
Why?
|
| Self Expandable Metallic Stents | 2 | 2019 | 7 | 0.700 |
Why?
|
| Ultrasonography, Interventional | 5 | 2020 | 124 | 0.680 |
Why?
|
| Treatment Outcome | 18 | 2024 | 8257 | 0.660 |
Why?
|
| Biodiversity | 6 | 2015 | 208 | 0.660 |
Why?
|
| Esophagoscopy | 7 | 2023 | 90 | 0.660 |
Why?
|
| RNA, Ribosomal, 16S | 11 | 2015 | 248 | 0.640 |
Why?
|
| Pancreatitis | 3 | 2023 | 86 | 0.620 |
Why?
|
| Observer Variation | 5 | 2015 | 611 | 0.620 |
Why?
|
| Environmental Microbiology | 4 | 2015 | 22 | 0.610 |
Why?
|
| Rectum | 2 | 2016 | 148 | 0.610 |
Why?
|
| Male | 50 | 2024 | 42476 | 0.610 |
Why?
|
| Bacterial Physiological Phenomena | 2 | 2015 | 42 | 0.600 |
Why?
|
| Environmental Monitoring | 2 | 2015 | 75 | 0.600 |
Why?
|
| Bile Duct Neoplasms | 3 | 2015 | 90 | 0.600 |
Why?
|
| Aged | 34 | 2024 | 19191 | 0.590 |
Why?
|
| Colon | 6 | 2017 | 511 | 0.590 |
Why?
|
| Abdominal Pain | 2 | 2010 | 138 | 0.580 |
Why?
|
| Carcinoma in Situ | 1 | 2017 | 53 | 0.570 |
Why?
|
| Ecosystem | 6 | 2015 | 349 | 0.570 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2018 | 127 | 0.550 |
Why?
|
| Gastric Mucosa | 3 | 2024 | 68 | 0.540 |
Why?
|
| Defecation | 1 | 2016 | 23 | 0.540 |
Why?
|
| Rectal Diseases | 1 | 2016 | 24 | 0.530 |
Why?
|
| Female | 47 | 2024 | 46282 | 0.530 |
Why?
|
| Nurses | 2 | 2013 | 40 | 0.530 |
Why?
|
| Choristoma | 1 | 2016 | 68 | 0.520 |
Why?
|
| Middle Aged | 35 | 2024 | 26017 | 0.510 |
Why?
|
| Microscopy, Confocal | 7 | 2017 | 277 | 0.510 |
Why?
|
| Soil | 4 | 2015 | 45 | 0.510 |
Why?
|
| Stomach | 1 | 2016 | 111 | 0.510 |
Why?
|
| Abdominal Abscess | 1 | 2015 | 23 | 0.510 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 35 | 0.500 |
Why?
|
| Amoeba | 1 | 2015 | 5 | 0.500 |
Why?
|
| Colonic Neoplasms | 4 | 2014 | 572 | 0.490 |
Why?
|
| Cholangiocarcinoma | 1 | 2015 | 76 | 0.490 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2015 | 83 | 0.480 |
Why?
|
| Legionella pneumophila | 1 | 2015 | 66 | 0.470 |
Why?
|
| Needles | 2 | 2016 | 36 | 0.470 |
Why?
|
| Pancreatic Cyst | 5 | 2015 | 28 | 0.460 |
Why?
|
| Sphingomonadaceae | 1 | 2013 | 2 | 0.460 |
Why?
|
| Retrospective Studies | 16 | 2024 | 9072 | 0.430 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 4 | 2016 | 25 | 0.420 |
Why?
|
| Accidents, Home | 1 | 2012 | 16 | 0.410 |
Why?
|
| Hospitals | 1 | 2015 | 300 | 0.410 |
Why?
|
| Dissection | 3 | 2017 | 44 | 0.390 |
Why?
|
| Mass Screening | 2 | 2013 | 637 | 0.380 |
Why?
|
| Geologic Sediments | 3 | 2014 | 19 | 0.380 |
Why?
|
| Interleukin-10 | 3 | 2015 | 151 | 0.370 |
Why?
|
| Prospective Studies | 10 | 2021 | 4305 | 0.370 |
Why?
|
| Carbon | 3 | 2015 | 90 | 0.370 |
Why?
|
| Aged, 80 and over | 15 | 2024 | 6819 | 0.360 |
Why?
|
| Archaea | 2 | 2014 | 18 | 0.360 |
Why?
|
| Bacterial Infections | 1 | 2012 | 184 | 0.360 |
Why?
|
| Electrosurgery | 2 | 2024 | 10 | 0.350 |
Why?
|
| Petroleum Pollution | 2 | 2014 | 11 | 0.350 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 479 | 0.350 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2015 | 581 | 0.340 |
Why?
|
| Operative Time | 4 | 2024 | 143 | 0.340 |
Why?
|
| Gastrointestinal Diseases | 2 | 2013 | 151 | 0.330 |
Why?
|
| Intestinal Mucosa | 3 | 2024 | 805 | 0.330 |
Why?
|
| Metagenome | 4 | 2014 | 105 | 0.330 |
Why?
|
| Lymphoma | 1 | 2011 | 265 | 0.330 |
Why?
|
| Postoperative Complications | 3 | 2018 | 2284 | 0.330 |
Why?
|
| Pancreatitis, Acute Necrotizing | 2 | 2021 | 18 | 0.330 |
Why?
|
| Biliary Tract Neoplasms | 2 | 2020 | 33 | 0.310 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2020 | 72 | 0.300 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2007 | 8 | 0.300 |
Why?
|
| Esophagitis, Peptic | 1 | 2007 | 10 | 0.290 |
Why?
|
| Video Recording | 3 | 2020 | 203 | 0.290 |
Why?
|
| Delphi Technique | 2 | 2024 | 95 | 0.280 |
Why?
|
| Developing Countries | 1 | 2007 | 77 | 0.280 |
Why?
|
| Food | 1 | 2007 | 90 | 0.280 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2007 | 73 | 0.280 |
Why?
|
| Tomography, Optical Coherence | 2 | 2019 | 136 | 0.270 |
Why?
|
| Hydrogen | 2 | 2014 | 47 | 0.270 |
Why?
|
| Sigmoidoscopy | 1 | 2006 | 36 | 0.260 |
Why?
|
| Referral and Consultation | 2 | 2024 | 342 | 0.260 |
Why?
|
| Inflammation | 3 | 2015 | 971 | 0.260 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.250 |
Why?
|
| Consensus | 2 | 2024 | 358 | 0.250 |
Why?
|
| Life | 1 | 2014 | 7 | 0.250 |
Why?
|
| DNA, Bacterial | 4 | 2015 | 243 | 0.250 |
Why?
|
| Acetobacterium | 1 | 2014 | 1 | 0.250 |
Why?
|
| Clinical Competence | 3 | 2024 | 785 | 0.240 |
Why?
|
| Biota | 2 | 2014 | 20 | 0.240 |
Why?
|
| Antioxidants | 2 | 2014 | 226 | 0.240 |
Why?
|
| Acetates | 1 | 2014 | 65 | 0.240 |
Why?
|
| Ascorbic Acid | 1 | 2004 | 38 | 0.240 |
Why?
|
| Plant Preparations | 1 | 2004 | 21 | 0.240 |
Why?
|
| Adenomatous Polyps | 2 | 2015 | 13 | 0.240 |
Why?
|
| Intestinal Polyps | 2 | 2015 | 27 | 0.240 |
Why?
|
| Acetic Acid | 1 | 2014 | 8 | 0.240 |
Why?
|
| Biopsy | 5 | 2019 | 1185 | 0.230 |
Why?
|
| Equipment Design | 5 | 2015 | 415 | 0.230 |
Why?
|
| Sulfates | 1 | 2014 | 57 | 0.230 |
Why?
|
| Ciona intestinalis | 1 | 2014 | 26 | 0.230 |
Why?
|
| Cannabis | 1 | 2014 | 35 | 0.230 |
Why?
|
| Authorship | 1 | 2024 | 23 | 0.230 |
Why?
|
| Enterobacter cloacae | 2 | 2021 | 8 | 0.230 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 39 | 0.230 |
Why?
|
| Hepatitis C, Chronic | 1 | 2004 | 91 | 0.220 |
Why?
|
| Veterans | 1 | 2004 | 84 | 0.220 |
Why?
|
| Biliary Tract Diseases | 2 | 2013 | 36 | 0.220 |
Why?
|
| Iron | 1 | 2014 | 168 | 0.220 |
Why?
|
| Dexamethasone | 1 | 2015 | 344 | 0.220 |
Why?
|
| Klebsiella pneumoniae | 2 | 2021 | 39 | 0.220 |
Why?
|
| Phytotherapy | 1 | 2004 | 136 | 0.220 |
Why?
|
| Risk Factors | 6 | 2024 | 5500 | 0.210 |
Why?
|
| Precancerous Conditions | 2 | 2023 | 200 | 0.210 |
Why?
|
| Adult | 21 | 2023 | 26654 | 0.210 |
Why?
|
| Quality Indicators, Health Care | 1 | 2024 | 147 | 0.210 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 346 | 0.210 |
Why?
|
| United States | 11 | 2024 | 7006 | 0.210 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 117 | 0.210 |
Why?
|
| Surveys and Questionnaires | 5 | 2021 | 2633 | 0.200 |
Why?
|
| Carbon Dioxide | 3 | 2015 | 201 | 0.200 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 168 | 0.200 |
Why?
|
| Internet | 2 | 2021 | 320 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 234 | 0.190 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 360 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 123 | 0.190 |
Why?
|
| Mentoring | 1 | 2021 | 32 | 0.180 |
Why?
|
| Quality of Life | 2 | 2021 | 1671 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1365 | 0.180 |
Why?
|
| Lifting | 1 | 2020 | 12 | 0.180 |
Why?
|
| Videoconferencing | 1 | 2020 | 15 | 0.180 |
Why?
|
| Time Factors | 4 | 2024 | 5344 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2019 | 2876 | 0.180 |
Why?
|
| Societies, Medical | 1 | 2024 | 579 | 0.180 |
Why?
|
| Nitrogen | 3 | 2015 | 73 | 0.180 |
Why?
|
| Databases, Factual | 3 | 2019 | 856 | 0.180 |
Why?
|
| Prosthesis Failure | 2 | 2019 | 116 | 0.180 |
Why?
|
| Teaching Rounds | 1 | 2020 | 26 | 0.170 |
Why?
|
| Clinical Clerkship | 1 | 2021 | 118 | 0.170 |
Why?
|
| Biodegradation, Environmental | 2 | 2014 | 18 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 3 | 2014 | 237 | 0.170 |
Why?
|
| Image Enhancement | 2 | 2014 | 567 | 0.170 |
Why?
|
| Culture Techniques | 2 | 2016 | 91 | 0.170 |
Why?
|
| Portal Vein | 2 | 2020 | 120 | 0.170 |
Why?
|
| Gastrectomy | 1 | 2019 | 70 | 0.160 |
Why?
|
| Simulation Training | 1 | 2020 | 98 | 0.160 |
Why?
|
| Glucuronosyltransferase | 1 | 2020 | 186 | 0.160 |
Why?
|
| Genome, Bacterial | 2 | 2014 | 149 | 0.160 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 198 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 510 | 0.150 |
Why?
|
| HIV Infections | 1 | 2007 | 844 | 0.150 |
Why?
|
| Cardia | 1 | 2017 | 5 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2015 | 1097 | 0.150 |
Why?
|
| Obesity | 2 | 2014 | 971 | 0.150 |
Why?
|
| Seawater | 2 | 2014 | 45 | 0.140 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 3027 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.140 |
Why?
|
| RNA, Bacterial | 2 | 2015 | 111 | 0.140 |
Why?
|
| Electrocoagulation | 2 | 2013 | 23 | 0.140 |
Why?
|
| Capsule Endoscopes | 2 | 2013 | 5 | 0.140 |
Why?
|
| Sclerotherapy | 2 | 2013 | 16 | 0.140 |
Why?
|
| Temperature | 2 | 2015 | 406 | 0.140 |
Why?
|
| Attitude to Health | 1 | 2018 | 223 | 0.140 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 197 | 0.130 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 19 | 0.130 |
Why?
|
| Hemostasis, Endoscopic | 2 | 2016 | 16 | 0.130 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 3013 | 0.130 |
Why?
|
| Plasmids | 2 | 2014 | 291 | 0.130 |
Why?
|
| Perception | 2 | 2018 | 179 | 0.130 |
Why?
|
| Esophageal Diseases | 2 | 2013 | 27 | 0.130 |
Why?
|
| Registries | 2 | 2019 | 789 | 0.130 |
Why?
|
| Duodenoscopy | 1 | 2015 | 9 | 0.130 |
Why?
|
| Palliative Care | 1 | 2017 | 264 | 0.130 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2015 | 126 | 0.130 |
Why?
|
| Ventilation | 1 | 2015 | 8 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 260 | 0.130 |
Why?
|
| Fiber Optic Technology | 1 | 2015 | 36 | 0.130 |
Why?
|
| Grassland | 1 | 2015 | 6 | 0.130 |
Why?
|
| Poaceae | 1 | 2015 | 19 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.120 |
Why?
|
| Polyphenols | 1 | 2014 | 13 | 0.120 |
Why?
|
| Ammonium Compounds | 1 | 2014 | 8 | 0.120 |
Why?
|
| Duodenum | 1 | 2015 | 103 | 0.120 |
Why?
|
| Photochemotherapy | 1 | 2015 | 101 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 969 | 0.120 |
Why?
|
| Triticum | 1 | 2014 | 32 | 0.120 |
Why?
|
| Humidity | 1 | 2015 | 91 | 0.120 |
Why?
|
| Esophagus | 3 | 2013 | 106 | 0.120 |
Why?
|
| Satellite Imagery | 1 | 2014 | 5 | 0.120 |
Why?
|
| Predictive Value of Tests | 6 | 2015 | 1726 | 0.120 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2014 | 8 | 0.120 |
Why?
|
| Dietary Fiber | 1 | 2014 | 44 | 0.120 |
Why?
|
| Water Microbiology | 1 | 2014 | 13 | 0.120 |
Why?
|
| Bronchi | 1 | 2015 | 229 | 0.120 |
Why?
|
| Household Articles | 1 | 2014 | 15 | 0.120 |
Why?
|
| Ecology | 1 | 2015 | 74 | 0.120 |
Why?
|
| Oceans and Seas | 1 | 2014 | 30 | 0.120 |
Why?
|
| Epsilonproteobacteria | 1 | 2014 | 3 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2015 | 483 | 0.120 |
Why?
|
| Optical Imaging | 1 | 2014 | 51 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 604 | 0.120 |
Why?
|
| Groundwater | 1 | 2014 | 11 | 0.120 |
Why?
|
| Alteromonadaceae | 1 | 2014 | 2 | 0.120 |
Why?
|
| Wine | 1 | 2014 | 5 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 266 | 0.120 |
Why?
|
| Gammaproteobacteria | 1 | 2014 | 7 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 775 | 0.120 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 64 | 0.120 |
Why?
|
| Proctoscopes | 1 | 2013 | 1 | 0.120 |
Why?
|
| Hemorrhoids | 1 | 2013 | 5 | 0.120 |
Why?
|
| Viruses | 1 | 2014 | 78 | 0.120 |
Why?
|
| Virulence | 1 | 2015 | 280 | 0.110 |
Why?
|
| Information Systems | 1 | 2013 | 29 | 0.110 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2013 | 16 | 0.110 |
Why?
|
| Cyanoacrylates | 1 | 2013 | 5 | 0.110 |
Why?
|
| Overweight | 1 | 2014 | 119 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 866 | 0.110 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2013 | 15 | 0.110 |
Why?
|
| Electric Power Supplies | 1 | 2013 | 8 | 0.110 |
Why?
|
| Mediastinal Diseases | 1 | 2013 | 22 | 0.110 |
Why?
|
| Nutritional Status | 1 | 2013 | 81 | 0.110 |
Why?
|
| Digestive System Diseases | 1 | 2013 | 18 | 0.110 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2013 | 34 | 0.110 |
Why?
|
| Ants | 1 | 2014 | 53 | 0.110 |
Why?
|
| Tissue Adhesives | 1 | 2013 | 23 | 0.110 |
Why?
|
| Odorants | 1 | 2014 | 70 | 0.110 |
Why?
|
| Cyst Fluid | 1 | 2013 | 3 | 0.110 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2013 | 39 | 0.110 |
Why?
|
| Thrombin | 1 | 2013 | 61 | 0.110 |
Why?
|
| Dilatation | 1 | 2013 | 48 | 0.110 |
Why?
|
| Genotype | 2 | 2020 | 1850 | 0.110 |
Why?
|
| Ampulla of Vater | 1 | 2013 | 23 | 0.110 |
Why?
|
| Laser Coagulation | 1 | 2013 | 56 | 0.110 |
Why?
|
| Capsule Endoscopy | 1 | 2013 | 33 | 0.110 |
Why?
|
| Fungi | 1 | 2013 | 66 | 0.110 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2013 | 40 | 0.110 |
Why?
|
| India | 1 | 2013 | 125 | 0.110 |
Why?
|
| Insufflation | 1 | 2013 | 10 | 0.110 |
Why?
|
| Rectal Neoplasms | 1 | 2014 | 130 | 0.110 |
Why?
|
| Oxidation-Reduction | 3 | 2014 | 388 | 0.110 |
Why?
|
| Precision Medicine | 1 | 2017 | 412 | 0.110 |
Why?
|
| Japan | 1 | 2013 | 304 | 0.110 |
Why?
|
| Feces | 3 | 2015 | 331 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2013 | 52 | 0.110 |
Why?
|
| Saliva | 1 | 2014 | 124 | 0.110 |
Why?
|
| Hemostatics | 1 | 2013 | 58 | 0.110 |
Why?
|
| Smell | 1 | 2014 | 111 | 0.110 |
Why?
|
| Catheter Ablation | 1 | 2015 | 253 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2013 | 237 | 0.110 |
Why?
|
| Pakistan | 1 | 2012 | 15 | 0.100 |
Why?
|
| Bile Duct Diseases | 1 | 2012 | 23 | 0.100 |
Why?
|
| Hospitals, Private | 1 | 2012 | 4 | 0.100 |
Why?
|
| Plethysmography, Impedance | 1 | 2012 | 4 | 0.100 |
Why?
|
| Esophageal pH Monitoring | 1 | 2012 | 12 | 0.100 |
Why?
|
| Wound Closure Techniques | 1 | 2012 | 15 | 0.100 |
Why?
|
| Family | 1 | 2014 | 325 | 0.100 |
Why?
|
| Bile Ducts | 1 | 2012 | 59 | 0.100 |
Why?
|
| Manometry | 1 | 2012 | 44 | 0.100 |
Why?
|
| Young Adult | 6 | 2019 | 6325 | 0.100 |
Why?
|
| Logistic Models | 2 | 2007 | 1213 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2014 | 327 | 0.100 |
Why?
|
| Light | 2 | 2010 | 293 | 0.100 |
Why?
|
| Cystadenoma, Serous | 1 | 2011 | 15 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1845 | 0.100 |
Why?
|
| Genomics | 1 | 2017 | 764 | 0.100 |
Why?
|
| Jaundice, Obstructive | 1 | 2011 | 10 | 0.100 |
Why?
|
| Pancreatic Ducts | 1 | 2011 | 28 | 0.100 |
Why?
|
| Prevalence | 2 | 2007 | 1243 | 0.100 |
Why?
|
| Critical Illness | 1 | 2014 | 307 | 0.100 |
Why?
|
| Chicago | 4 | 2020 | 1428 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 264 | 0.090 |
Why?
|
| Water | 1 | 2013 | 284 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2015 | 1098 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2013 | 122 | 0.090 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2011 | 103 | 0.090 |
Why?
|
| Seasons | 1 | 2012 | 238 | 0.090 |
Why?
|
| Anxiety | 1 | 2013 | 308 | 0.090 |
Why?
|
| Selection, Genetic | 1 | 2015 | 512 | 0.090 |
Why?
|
| Carcinoma | 1 | 2014 | 443 | 0.090 |
Why?
|
| Animals | 8 | 2015 | 27411 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 306 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 446 | 0.090 |
Why?
|
| Patient Preference | 1 | 2011 | 111 | 0.090 |
Why?
|
| Conscious Sedation | 2 | 2011 | 68 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2011 | 1598 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 2017 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 2015 | 0.080 |
Why?
|
| Constriction, Pathologic | 3 | 2016 | 217 | 0.080 |
Why?
|
| Age of Onset | 1 | 2010 | 313 | 0.080 |
Why?
|
| Infant | 2 | 2013 | 3164 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2014 | 502 | 0.080 |
Why?
|
| Sex Factors | 2 | 2024 | 1069 | 0.080 |
Why?
|
| Metals | 3 | 2016 | 93 | 0.080 |
Why?
|
| Pediatrics | 1 | 2012 | 356 | 0.080 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2007 | 4 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1862 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2015 | 782 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 894 | 0.070 |
Why?
|
| Communication | 1 | 2011 | 458 | 0.070 |
Why?
|
| Anti-Ulcer Agents | 1 | 2007 | 22 | 0.070 |
Why?
|
| Asthma | 1 | 2015 | 977 | 0.070 |
Why?
|
| Tropical Climate | 1 | 2007 | 31 | 0.070 |
Why?
|
| Asia | 1 | 2007 | 100 | 0.070 |
Why?
|
| Africa | 1 | 2007 | 101 | 0.070 |
Why?
|
| Proton Pump Inhibitors | 1 | 2007 | 34 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 146 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 306 | 0.070 |
Why?
|
| Disease Progression | 2 | 2023 | 1490 | 0.070 |
Why?
|
| Base Sequence | 2 | 2014 | 2328 | 0.070 |
Why?
|
| Adolescent | 3 | 2019 | 9275 | 0.070 |
Why?
|
| Catheterization | 1 | 2007 | 237 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 839 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2011 | 626 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2015 | 2003 | 0.060 |
Why?
|
| Radiography | 1 | 2007 | 809 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2015 | 147 | 0.060 |
Why?
|
| Computer Systems | 2 | 2019 | 79 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2012 | 3739 | 0.060 |
Why?
|
| Plastics | 2 | 2016 | 7 | 0.060 |
Why?
|
| Echinacea | 1 | 2004 | 2 | 0.060 |
Why?
|
| Germ-Free Life | 1 | 2014 | 75 | 0.060 |
Why?
|
| Rhizosphere | 1 | 2014 | 3 | 0.060 |
Why?
|
| Pacific Ocean | 1 | 2014 | 18 | 0.060 |
Why?
|
| Desulfotomaculum | 1 | 2014 | 1 | 0.060 |
Why?
|
| Comamonadaceae | 1 | 2014 | 2 | 0.060 |
Why?
|
| Deltaproteobacteria | 1 | 2014 | 2 | 0.060 |
Why?
|
| Electrodes | 1 | 2014 | 88 | 0.060 |
Why?
|
| Clostridium | 1 | 2014 | 23 | 0.060 |
Why?
|
| Cannabinoids | 1 | 2014 | 12 | 0.060 |
Why?
|
| Competency-Based Education | 1 | 2024 | 37 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 374 | 0.060 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 71 | 0.060 |
Why?
|
| Gene Library | 1 | 2014 | 133 | 0.060 |
Why?
|
| California | 1 | 2014 | 146 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2006 | 254 | 0.060 |
Why?
|
| Bacteroidetes | 1 | 2014 | 39 | 0.060 |
Why?
|
| Plant Roots | 1 | 2014 | 107 | 0.060 |
Why?
|
| Tertiary Care Centers | 2 | 2015 | 107 | 0.060 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 160 | 0.060 |
Why?
|
| Larva | 1 | 2014 | 122 | 0.060 |
Why?
|
| Freezing | 1 | 2013 | 32 | 0.060 |
Why?
|
| DNA, Ribosomal | 1 | 2013 | 46 | 0.060 |
Why?
|
| Sexism | 1 | 2024 | 54 | 0.050 |
Why?
|
| DNA Primers | 1 | 2014 | 544 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 3223 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 322 | 0.050 |
Why?
|
| Physicians, Women | 1 | 2024 | 57 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2013 | 160 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 282 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 922 | 0.050 |
Why?
|
| Panax | 1 | 2004 | 170 | 0.050 |
Why?
|
| Systems Biology | 1 | 2013 | 44 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 345 | 0.050 |
Why?
|
| Metabolomics | 1 | 2013 | 75 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2015 | 491 | 0.050 |
Why?
|
| Connecticut | 2 | 2011 | 26 | 0.050 |
Why?
|
| Reference Standards | 1 | 2021 | 144 | 0.050 |
Why?
|
| Necrosis | 1 | 2021 | 210 | 0.050 |
Why?
|
| Learning Curve | 1 | 2021 | 19 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 2760 | 0.050 |
Why?
|
| Child | 1 | 2012 | 7184 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2014 | 774 | 0.050 |
Why?
|
| Universities | 1 | 2021 | 148 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 3669 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2013 | 872 | 0.040 |
Why?
|
| Injections | 1 | 2020 | 116 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 395 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 248 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2019 | 22 | 0.040 |
Why?
|
| Leucovorin | 1 | 2020 | 224 | 0.040 |
Why?
|
| Career Mobility | 1 | 2019 | 32 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2024 | 398 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 2306 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 286 | 0.040 |
Why?
|
| Phylogeny | 1 | 2014 | 1190 | 0.040 |
Why?
|
| Pregnancy | 1 | 2006 | 3025 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 789 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2020 | 560 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 853 | 0.040 |
Why?
|
| Career Choice | 1 | 2019 | 148 | 0.040 |
Why?
|
| Transcriptome | 1 | 2013 | 632 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 337 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 417 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 282 | 0.040 |
Why?
|
| Models, Biological | 2 | 2014 | 1767 | 0.040 |
Why?
|
| Citrobacter freundii | 1 | 2016 | 2 | 0.030 |
Why?
|
| Hafnia alvei | 1 | 2016 | 2 | 0.030 |
Why?
|
| Klebsiella oxytoca | 1 | 2016 | 2 | 0.030 |
Why?
|
| Pseudomonas putida | 1 | 2016 | 6 | 0.030 |
Why?
|
| Sphingomonas | 1 | 2016 | 4 | 0.030 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2016 | 3 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2017 | 112 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 181 | 0.030 |
Why?
|
| Mice | 2 | 2015 | 11782 | 0.030 |
Why?
|
| Acinetobacter baumannii | 1 | 2016 | 27 | 0.030 |
Why?
|
| Videotape Recording | 1 | 2016 | 48 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 150 | 0.030 |
Why?
|
| Immunomagnetic Separation | 1 | 2015 | 8 | 0.030 |
Why?
|
| Smad4 Protein | 1 | 2015 | 24 | 0.030 |
Why?
|
| Keratins | 1 | 2015 | 63 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2015 | 48 | 0.030 |
Why?
|
| Radiologists | 1 | 2016 | 47 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 128 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 115 | 0.030 |
Why?
|
| Gastroenterologists | 1 | 2016 | 31 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 125 | 0.030 |
Why?
|
| Urease | 1 | 2015 | 3 | 0.030 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2015 | 6 | 0.030 |
Why?
|
| Colonoscopes | 1 | 2015 | 13 | 0.030 |
Why?
|
| Tibet | 1 | 2015 | 19 | 0.030 |
Why?
|
| Nitrogen Oxides | 1 | 2015 | 15 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2015 | 84 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 200 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 119 | 0.030 |
Why?
|
| Edible Grain | 1 | 2014 | 9 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2015 | 83 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 112 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2014 | 32 | 0.030 |
Why?
|
| Drug Resistance, Fungal | 1 | 2014 | 8 | 0.030 |
Why?
|
| Beds | 1 | 2014 | 5 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2014 | 65 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2014 | 24 | 0.030 |
Why?
|
| Floors and Floorcoverings | 1 | 2014 | 7 | 0.030 |
Why?
|
| Pets | 1 | 2014 | 9 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 308 | 0.030 |
Why?
|
| Candida albicans | 1 | 2014 | 32 | 0.030 |
Why?
|
| Enterobacteriaceae | 1 | 2014 | 22 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2014 | 43 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2015 | 112 | 0.030 |
Why?
|
| England | 1 | 2014 | 38 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 202 | 0.030 |
Why?
|
| Equipment Reuse | 1 | 2014 | 7 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 23 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 126 | 0.030 |
Why?
|
| Enterococcus | 1 | 2014 | 35 | 0.030 |
Why?
|
| Foot | 1 | 2014 | 52 | 0.030 |
Why?
|
| Body Composition | 1 | 2014 | 71 | 0.030 |
Why?
|
| Sulfur | 1 | 2014 | 29 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 164 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2014 | 47 | 0.030 |
Why?
|
| Surface Properties | 1 | 2014 | 131 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 62 | 0.030 |
Why?
|
| Fusobacteria | 1 | 2014 | 1 | 0.030 |
Why?
|
| Proteobacteria | 1 | 2014 | 6 | 0.030 |
Why?
|
| Rivers | 1 | 2014 | 19 | 0.030 |
Why?
|
| Gulf of Mexico | 1 | 2014 | 5 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 2014 | 35 | 0.030 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2014 | 11 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2014 | 75 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2014 | 42 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 227 | 0.030 |
Why?
|
| Siberia | 1 | 2013 | 12 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 232 | 0.030 |
Why?
|
| Actinobacteria | 1 | 2014 | 11 | 0.030 |
Why?
|
| China | 1 | 2014 | 233 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2013 | 7 | 0.030 |
Why?
|
| Diathermy | 1 | 2013 | 2 | 0.030 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2013 | 17 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2014 | 67 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2014 | 48 | 0.030 |
Why?
|
| Nose | 1 | 2014 | 94 | 0.030 |
Why?
|
| Infrared Rays | 1 | 2013 | 17 | 0.030 |
Why?
|
| Data Compression | 1 | 2013 | 5 | 0.030 |
Why?
|
| Ligation | 1 | 2013 | 51 | 0.030 |
Why?
|
| Microcomputers | 1 | 2013 | 26 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 529 | 0.030 |
Why?
|
| Life Style | 1 | 2014 | 173 | 0.030 |
Why?
|
| Virulence Factors | 1 | 2014 | 112 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 76 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2015 | 231 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2014 | 192 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2014 | 69 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 2013 | 19 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2013 | 63 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 691 | 0.030 |
Why?
|
| Enzymes | 1 | 2013 | 47 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2015 | 188 | 0.030 |
Why?
|
| Hand | 1 | 2014 | 138 | 0.030 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2013 | 9 | 0.030 |
Why?
|
| Cryosurgery | 1 | 2013 | 54 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2013 | 57 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 316 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 450 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2013 | 121 | 0.030 |
Why?
|
| Capnography | 1 | 2012 | 5 | 0.030 |
Why?
|
| Blood Pressure Monitors | 1 | 2012 | 8 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2013 | 169 | 0.030 |
Why?
|
| Air | 1 | 2013 | 62 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 150 | 0.030 |
Why?
|
| Intestinal Neoplasms | 1 | 2013 | 67 | 0.030 |
Why?
|
| Clinical Alarms | 1 | 2012 | 16 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 323 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 576 | 0.030 |
Why?
|
| Abscess | 1 | 2013 | 94 | 0.030 |
Why?
|
| Proteome | 1 | 2014 | 133 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 80 | 0.030 |
Why?
|
| Cholesterol | 1 | 2014 | 360 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 416 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3789 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 695 | 0.030 |
Why?
|
| Esophageal Fistula | 1 | 2012 | 11 | 0.030 |
Why?
|
| Double-Balloon Enteroscopy | 1 | 2012 | 11 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 230 | 0.030 |
Why?
|
| Oximetry | 1 | 2012 | 81 | 0.030 |
Why?
|
| Proteomics | 1 | 2014 | 230 | 0.030 |
Why?
|
| Fluorescein | 1 | 2011 | 16 | 0.020 |
Why?
|
| Catheters | 1 | 2012 | 76 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2011 | 55 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2013 | 299 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 443 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2015 | 455 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 887 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2012 | 140 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2015 | 576 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 699 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 395 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2013 | 339 | 0.020 |
Why?
|
| Telemedicine | 1 | 2013 | 188 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2011 | 115 | 0.020 |
Why?
|
| Sepsis | 1 | 2014 | 322 | 0.020 |
Why?
|
| Celiac Disease | 1 | 2013 | 214 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 497 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2012 | 245 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1310 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 804 | 0.020 |
Why?
|
| Software | 1 | 2013 | 664 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2567 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2012 | 350 | 0.020 |
Why?
|
| Proteins | 1 | 2014 | 787 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 448 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1434 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2415 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 1769 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2012 | 753 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1048 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2018 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1553 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2013 | 762 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2375 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 1144 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 4143 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2664 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3452 | 0.010 |
Why?
|